Navigation Links
CalbaTech, Inc. Officially Changes Name to LifeStem International, Inc.; Lists New Symbol (LSTM) and Launches New Web Site
Date:5/1/2008

LAGUNA HILLS, Calif., May 1 /PRNewswire-FirstCall/ -- LifeStem International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, Inc. (OTC Bulletin Board: CLBE), the emerging life sciences company concentrating on the collection and banking of adult stem cells for possible future therapeutic uses, today announced that as of May 2, it will have officially changed its name, obtained a new trading symbol, effected a 3000 for 1 reverse stock split, and launched its new website at http://www.lifesteminternational.com.

The new web site gives significant background on the Company's proprietary Stem Cell MicroBank(TM), its unique method of stem cell banking that allows healthy individuals to collect and store their stem cells for possible future therapeutic use. The web site also explains the Company's Research Reagents Division, which includes K-D Medical, Inc. and MoleculA, Inc. in Columbia, Maryland. Also included on the site is information for the investor on our financial filings and news releases, as well as information on management and the scientific advisory board.

LifeStem's Stem Cell MicroBank(TM) Service is a process that involves the harvesting of adult stem cells in micro quantities from both blood and adipose tissue. The cells are then cryopreserved for future possible therapeutic applications and therapies, such as grafting new skin cells for burn victims, regenerating corneas and producing and regulating insulin for diabetics.

About LifeStem International, Inc.

LifeStem International, Inc. (OTC Bulletin Board: LSTM) is the emerging life sciences company (http://www.lifesteminternational.com), concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells.

Note: Certain statements in this news release may contain "forward-looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to being in a large and growing market, exhibiting rapid growth characteristics, and having a growth strategy, are forward-looking statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or assumptions in this press release include the risk that we will not be able to grow our revenues and market share, the risk that our prices do not remain competitive and the risk that we will not achieve profitability. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Contact: Paul Knopick

E & E Communications

949/707-5365

pknopick@eandecommunications.com


'/>"/>
SOURCE LifeStem International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Albertsons Officially Launches Healthy Eaters(TM) Field Trip Program
3. University Hospital of Bordeaux Officially Opens New Electrophysiology Lab
4. Hooray for the Bay! San Francisco Officially Named Best Place to Leave Your Heart...and Keep Your Health
5. Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company
6. CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville
7. Genetic Changes May Dictate Course of Acute Myeloid Leukemia
8. GSK Announces Changes to Corporate Executive Team
9. Changes to Family and Medical Leave Act Clarify Employer Responsibilities
10. Procter & Gamble Announces Board Changes
11. Physicians Anticipate Changes in Their Usage of Hip Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Ontario (PRWEB) , ... February 05, 2016 , ... After ... Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to ... Scarborough Hospital. He successfully completed his first three-year term as chief and began a ...
(Date:2/5/2016)... , ... February 05, 2016 , ... The American public ... such water may be safer than regular municipal or well water. The recent experience ... host Sharon Kleyne, could go a long way toward increasing public acceptance of recycled ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot ... 2015 Best in KLAS: Software & Services for HIT Implementation Support & Staffing ... report independently ranks vendor performance by healthcare executives, managers and clinicians representing over ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... California Mobile Kitchens ... debut of their latest mobile kitchen model, featuring customizable stainless steel interiors and ... commercial kitchens for use anywhere in the U.S. Many of their units can ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016 Wegener Polyangiitis - ... Markets Direct,s, ,Wegener Polyangiitis - Pipeline Review, H2 ... therapeutic pipeline. This report provides comprehensive information ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Identifying and Commercializing First-in-Class Innovation ... disorder associated with chronic inflammation of the airways ... of COPD symptoms make the disease one of ... cause of death in the world. COPD is ...
(Date:2/4/2016)... 4, 2016 In response to the opioid abuse ... Commissioner for Medical Products and Tobacco, along with other FDA ... agency,s approach to opioid medications. The plan will focus on ... in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure that ...
Breaking Medicine Technology: